Health
-

Obesity drugs: Will Trump’s plan lower costs?
Feature Even $149 a month, the advertised price for a starting dose of a still-in-development GLP-1 pill on TrumpRx, will be too big a burden for the many Americans ‘struggling to afford groceries’
By The Week US Published
Feature -

The rise of tinned beans
The Week Recommends Protein-packed, affordable and easy to cook with, the humble legume is having a moment
By Will Barker, The Week UK Published
The Week Recommends -

More adults are dying before the age of 65
Under the radar The phenomenon is more pronounced in Black and low-income populations
By Devika Rao, The Week US Published
Under the radar -

Ultra-processed America
Feature Highly processed foods make up most of our diet. Is that so bad?
By The Week US Published
Feature -

‘Security is no longer a function only of missiles and fighter jets’
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published
Instant Opinion -

The plant-based portfolio diet focuses on heart health
The Explainer Its guidelines are flexible and vegan-friendly
By Devika Rao, The Week US Published
The Explainer -

Tips for surviving loneliness during the holiday season — with or without people
the week recommends Solitude is different from loneliness
By Scott Hocker, The Week US Published
the week recommends -

The rise in unregulated pregnancy scans
Under The Radar Industry body says some private scan clinics offer dangerously misleading advice
By Chas Newkey-Burden, The Week UK Published
Under The Radar -

Scientists have developed a broad-spectrum snake bite antivenom
Under the radar It works on some of the most dangerous species
By Devika Rao, The Week US Published
Under the radar -

Mar-a-Lago face: the Maga plastic surgery trend crossing party lines
Under the Radar The must-have accessory for Trump's inner circle does not come easy – or cheap
By The Week UK Last updated
Under the Radar -

The pros and cons of privatising the NHS
Pros and Cons Our free health service is 'in crisis' but there are fears a move to a US-style insurance model could lead to 'a two-tier' system that prioritises profits over patients
By The Week Staff Last updated
Pros and Cons -

Testosterone therapy in women highlights the lack of women’s health research
The explainer There is no FDA-approved testosterone product for women
By Devika Rao, The Week US Published
The explainer -

Covid-19 mRNA vaccines could help fight cancer
Under the radar They boost the immune system
By Devika Rao, The Week US Published
Under the radar -

The ‘menopause gold rush’
Under the Radar Women vulnerable to misinformation and marketing of ‘unregulated’ products
By Will Barker, The Week UK Published
Under the Radar
